Centene Corp.

  • Market Cap: Mid Cap
  • Industry: Healthcare Services
  • ISIN: US15135B1017
USD
38.85
0.04 (0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Centene Corp. stock-summary
stock-summary
Centene Corp.
Healthcare Services
Centene Corporation is a healthcare company. The Company provides a portfolio of services to government sponsored healthcare programs, focusing on under-insured and uninsured individuals. The Company operates through two segments: Managed Care and Specialty Services. The Company's Managed Care segment provides health plan coverage to individuals, through government subsidized programs, including Medicaid, the State Children's Health Insurance Program (CHIP), Long Term Care, Foster Care, dual-eligible individuals (Duals) and the Supplemental Security Income Program, also known as the Aged, Blind or Disabled Program (ABD), Medicare, and Health Insurance Marketplace. Its Specialty Services segment consists of its specialty companies offering a range of healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations, as well as to its own subsidiaries.
Company Coordinates stock-summary
Company Details
7700 Forsyth Blvd , ST. LOUIS MO : 63105-1807
stock-summary
Tel: 1 314 7254477
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 168 Schemes (42.72%)

Foreign Institutions

Held by 423 Foreign Institutions (24.4%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Michael Neidorff
Chairman of the Board, President, Chief Executive Officer
Mr. Orlando Ayala
Independent Director
Ms. Jessica Blume
Independent Director
Ms. H. James Dallas
Independent Director
Mr. Robert Ditmore
Presiding Independent Director
Mr. Frederick Eppinger
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
-259 Million
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

USD 14,661 Million (Mid Cap)

stock-summary
P/E

8.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.01

stock-summary
Return on Equity

7.71%

stock-summary
Price to Book

0.53